Optimizing individualized therapy decision-making in multiple myeloma (MM): integration and impact of the Revised Myeloma Comorbidity Index in the MM-tumor board.

Ann Hematol · 2025 · PMC11868216 · PMID 39305306

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

published a systematic review including 43 clinical trials considering frailty tools and showed an encouraging trend to incorporate frailty assessments in clinical evaluations and treatment decisions [ 10 ], in line with our data of the R-MCI-integration in TOS-MM-TBs in > 90%.

also in 151 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.